These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis. Menon IS Acta Univ Carol Med Monogr; 1972; 52():181-4. PubMed ID: 4669820 [No Abstract] [Full Text] [Related]
6. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases]. Czestochowska E Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036 [No Abstract] [Full Text] [Related]
7. [Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses]. Marbet GA; Duckert F; Biland L; Widmer LK Schweiz Med Wochenschr; 1985 Oct; 115(43):1505-6. PubMed ID: 4081679 [TBL] [Abstract][Full Text] [Related]
8. Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis. Korninger C; Lechner K; Niessner H; Gössinger H; Kundi M Thromb Haemost; 1984 Oct; 52(2):127-30. PubMed ID: 6523430 [TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic response in retinal venous occlusions and in diabetic retinopathy]. Peduzzi M; De Rosa L; Montanari F; Coccheri S Bull Mem Soc Fr Ophtalmol; 1978; 90():79-82. PubMed ID: 750023 [No Abstract] [Full Text] [Related]
10. Relation of blood coagulation, fibrinolysis and platelet aggregation tests to development of deep vein thrombosis in high risk medical patients. Stegnar M; Accetto B; Budihna N; Miklavcic L Acta Med Iugosl; 1981; 35(4):259-67. PubMed ID: 7325003 [No Abstract] [Full Text] [Related]
12. [Decreased fibrinolytic activity in venous walls of patients with venous thromboses]. Hach V; Heyland H; Walter-Fincke R; Scharrer I Vasa; 1985; 14(4):336-9. PubMed ID: 4072368 [No Abstract] [Full Text] [Related]
13. [Use of desmopressin (DDAVP) in the detection of decreased fibrinolytic capacity in persons with idiopathic venous thrombosis and myocardial infarct at a young age]. Cepelák V; Dvorák J Vnitr Lek; 1985 Mar; 31(3):232-9. PubMed ID: 4036009 [No Abstract] [Full Text] [Related]
14. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Robertson BR; Pandolfi M; Nilsson IM Acta Chir Scand; 1972; 138(5):429-36. PubMed ID: 5055974 [No Abstract] [Full Text] [Related]
15. [Arterial and venous thrombosis of the extremities]. Urano T; Sakaguchi S; Kamiya T; Ishii K; Takada Y; Takada A Rinsho Ketsueki; 1984 Jul; 25(7):1036-42. PubMed ID: 6502955 [No Abstract] [Full Text] [Related]
16. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802 [TBL] [Abstract][Full Text] [Related]
17. [A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis]. Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B Ugeskr Laeger; 1983 Jul; 145(30):2302-3. PubMed ID: 6685363 [No Abstract] [Full Text] [Related]
18. [Clinical surgery and fibrinolysis]. Murakami F; Kadota H Saishin Igaku; 1966 Feb; 21(2):284-91. PubMed ID: 5966315 [No Abstract] [Full Text] [Related]
19. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
20. The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary report. Aberg M; Isacson S; Nilsson IM Acta Chir Scand; 1974; 140(5):352-4. PubMed ID: 4854836 [No Abstract] [Full Text] [Related] [Next] [New Search]